Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Vertex Pharmaceuticals Inc. sell Robert W. Baird

Start price
€400.05
31.01.24 / 50%
Target price
€299.00
31.01.25
Performance (%)
7.86%
Price
€431.50
03.06.24
Summary
This prediction is currently active. The SELL prediction by Robert_W__Baird shows the price for Vertex Pharmaceuticals Inc. has slightly increased by 7.86%. This prediction currently runs until 31.01.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Vertex Pharmaceuticals Inc. 1.649% 1.649%
iShares Core DAX® -1.226% 2.804%
iShares Nasdaq 100 -1.845% 2.732%
iShares Nikkei 225® -1.132% -2.218%
iShares S&P 500 -0.980% 1.883%

Comments by Robert_W__Baird for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Sell
Perf. (%) 7.86%
Target price 299.000
Change
Ends at 31.01.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Robert W. Baird from a "neutral" rating to an "underperform" rating. They now have a $325.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat